Abstract
516. A Phase III Study of Belagenpumatucel-L, an Allogeneic Tumor Cell Vaccine, as Maintenance Therapy for Non-Small Cell Lung Cancer
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have